Topical LET Gel Drug Interactions
Currently displaying a list of 133 drugs known to interact with Topical LET Gel (epinephrine / lidocaine / tetracaine topical).
- 9 major drug interactions
- 118 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with Topical LET Gel
Note: Showing generic names only.
A
- acebutolol
- acetaminophen
- albuterol
- aminosalicylic acid
- amiodarone
- amyl nitrite
- arformoterol
- atenolol
- atovaquone
B
C
- carteolol
- carteolol ophthalmic
- carvedilol
- celecoxib
- chloroprocaine
- chloroquine
- cimetidine
- ciprofloxacin
- cocaine nasal
- cocaine topical
- cyclophosphamide
D
- dapsone
- dapsone topical
- desvenlafaxine
- dihydroergotamine
- divalproex sodium
- dofetilide
- dronedarone
- droxidopa
- duloxetine
E
F
H
I
- ibutilide
- ifosfamide
- indacaterol
- isocarboxazid
- isoetharine
- isoniazid
- isoproterenol
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
K
L
M
- mafenide topical
- mepivacaine
- metaproterenol
- methylene blue
- methylergonovine
- methysergide maleate
- metipranolol ophthalmic
- metoclopramide
- metoprolol
- mexiletine
- midodrine
- milnacipran
N
O
P
- penbutolol
- phenazopyridine
- phenelzine
- phenobarbital
- phenytoin
- pindolol
- pirbuterol
- prilocaine
- primaquine
- procaine
- procaine penicillin
- procarbazine
- propranolol
Q
R
S
- safinamide
- salmeterol
- selegiline
- sibutramine
- silver nitrate topical
- silver sulfadiazine topical
- sodium nitrite
- solriamfetol
- sotalol
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
- tafenoquine
- tapentadol
- terbutaline
- tetracaine
- timolol
- timolol ophthalmic
- tocainide
- tolcapone
- tranylcypromine
- trazodone
- trimethoprim
V
Topical LET Gel disease interactions
There are 7 disease interactions with Topical LET Gel (epinephrine / lidocaine / tetracaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- dehydration
- acidosis
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.